STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risksAn FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.Fuji Dream AirlinesneutralFuji Dream AirlinesGalleriGrailSep 23, 2026 · bySTAT
FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.Fuji Dream AirlinesneutralFuji Dream AirlinesGalleriGrailSep 23, 2026 · byMarketWatch
Will FDA advisers recommend a multi-cancer blood test for approval? They'll voteThe company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts will decide if the test should be recommended for FDA approval.Fuji Dream AirlinesneutralFuji Dream AirlinesGalleriGrailSep 23, 2026 · byNPR